ALGS vs MS · rev $3.6M vs P/E 20, $344.27B cap
Aligos Therapeutics Inc (ALGS) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
MS does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ALGS and MS stock pages for the full models.
Not investment advice.